TABLE 3.
Analysis of cardiac function via cardiac catheterization
| Ntg sham |
Ntg diabetic |
IGF-1R sham |
IGF-1R diabetic |
|
|---|---|---|---|---|
| n = 8 | n = 7 | n = 9 | n = 9 | |
| Heart rate (bpm) | 349 ± 10 | 364 ± 15 | 369 ± 17 | 372 ± 11 |
| Ao SBP (mmHg) | 107.8 ± 3.7 | 87.0 ± 3.3* | 99.4 ± 2.8 | 88.5 ± 2.8* |
| Ao DBP (mmHg) | 73.9 ± 3.6 | 59.2 ± 3.1* | 68.2 ± 2.5 | 60.5 ± 3.5 |
| LV+dP/dt (mmHg/s) | 7,237 ± 293 | 8,297 ± 586 | 8,628 ± 426† | 8,029 ± 557 |
| LV−dP/dt (mmHg/s) | −6,699 ± 361 | −5,543 ± 314† | −6,006 ± 284 | −5,500 ± 341 |
| LVSP (mmHg) | 102.8 ± 2.5 | 90.2 ± 2.2* | 96.9 ± 2.6 | 92.7 ± 3.1 |
Ao SBP, aortic systolic blood pressure; Ao DBP, aortic diastolic blood pressure; LVSP, left ventricular systolic pressure.
*P < 0.05 vs. sham of the same genotype;
†P < 0.05 vs. Ntg sham (on unpaired t test).